IE38651B1 - Improvements in or relating to an aqueous lipid emulsion for parenteral alimentation - Google Patents

Improvements in or relating to an aqueous lipid emulsion for parenteral alimentation

Info

Publication number
IE38651B1
IE38651B1 IE2289/73A IE228973A IE38651B1 IE 38651 B1 IE38651 B1 IE 38651B1 IE 2289/73 A IE2289/73 A IE 2289/73A IE 228973 A IE228973 A IE 228973A IE 38651 B1 IE38651 B1 IE 38651B1
Authority
IE
Ireland
Prior art keywords
acid
lipid emulsion
adjuster
emulsifier
relating
Prior art date
Application number
IE2289/73A
Other versions
IE38651L (en
Original Assignee
Seperic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seperic filed Critical Seperic
Publication of IE38651L publication Critical patent/IE38651L/en
Publication of IE38651B1 publication Critical patent/IE38651B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1397680 Nutrient composition SEPERIC 19 Dec 1973 [18 Jan 1973] 58819/73 Heading A5B A nutrient composition suitable for parenteral administration comprises an aqueous lipid emulsion of pH 7-8 containing (a) an emulsifier, (b) aminoacids in the aqueous phase including essential amino acids and arginine and (c) an acid pH adjuster. The lipid may be soyabean oil or cottonseed oil. The emulsifier may be egg or soyabean lecithin. The essential amino acids may be isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan and valine. The pH adjuster may be aspartic acid, malic acid, tartaric acid or citric acid. The composition may also include non-essential aminoacids, e.g. histidine, proline, alanine, serine, asparagine, tyrosine, glycine, cysteine and a glucidic supply, e.g. sorbitol. [GB1397680A]
IE2289/73A 1973-01-18 1973-12-18 Improvements in or relating to an aqueous lipid emulsion for parenteral alimentation IE38651B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7301705A FR2215212B1 (en) 1973-01-18 1973-01-18

Publications (2)

Publication Number Publication Date
IE38651L IE38651L (en) 1974-07-18
IE38651B1 true IE38651B1 (en) 1978-04-26

Family

ID=9113474

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2289/73A IE38651B1 (en) 1973-01-18 1973-12-18 Improvements in or relating to an aqueous lipid emulsion for parenteral alimentation

Country Status (12)

Country Link
AU (1) AU476180B2 (en)
BE (1) BE808823A (en)
CH (1) CH574716A5 (en)
DE (1) DE2303463C2 (en)
DK (1) DK134097B (en)
ES (1) ES422537A1 (en)
FR (1) FR2215212B1 (en)
GB (1) GB1397680A (en)
IE (1) IE38651B1 (en)
NL (1) NL7400673A (en)
SE (1) SE422152B (en)
ZA (1) ZA739667B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2530246A1 (en) * 1975-07-07 1977-01-13 Fresenius Chem Pharm Ind L-AMINO ACID MIXTURES FOR PARENTERAL OR ORAL USE
DE2531201C2 (en) * 1975-07-12 1986-05-28 Fresenius AG, 6380 Bad Homburg Amino acid infusion solutions for use in premature babies to young children
DE2531204C2 (en) * 1975-07-12 1987-01-22 Fresenius AG, 6380 Bad Homburg L-amino acid mixtures for parenteral or oral nutrition
DE2642768A1 (en) * 1976-09-23 1978-03-30 Fresenius Chem Pharm Ind MIXTURE CONTAINING ESSENTIAL AND NON-ESSENTIAL L-AMINO ACIDS FOR THE TREATMENT OF LIVER INSUFFICIENCY
FR2489145A1 (en) * 1980-09-04 1982-03-05 Geistlich Soehne Ag PHARMACEUTICAL COMPOSITIONS ACCELERATING THE HEALING OF INJURIES
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition
GB9502131D0 (en) * 1995-02-03 1995-03-22 Mini Agriculture & Fisheries Amino acid compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2662046A (en) * 1948-06-19 1953-12-08 Merck & Co Inc Parenteral amino acid solution
US3080234A (en) * 1960-12-06 1963-03-05 Pfizer & Co C Method of improving the efficiency of amino acid diets
AT297935B (en) * 1968-05-09 1972-04-10 Astra Ab Process for the preparation of an infusion solution of essential amino acids for intravenous delivery in uremic conditions
DE1934317B1 (en) * 1969-07-07 1970-10-15 Braun Fa B Process for the production of stable, non-pyrogenic, intravenous administrable, aqueous, amino acid-containing fat emulsions
DE1792294B1 (en) * 1968-08-16 1970-07-09 Braun Fa B Process for the production of stable, non-pyrogenic, intravenous administrable, aqueous, amino acid-containing fat emulsions
ES392481A1 (en) * 1970-06-29 1975-03-01 Procter & Gamble Stable oil- and water-soluble protein-containing product

Also Published As

Publication number Publication date
ES422537A1 (en) 1976-05-01
AU6392073A (en) 1975-06-26
DE2303463A1 (en) 1974-07-25
BE808823A (en) 1974-04-16
DK134097C (en) 1977-02-14
ZA739667B (en) 1974-11-27
GB1397680A (en) 1975-06-18
FR2215212B1 (en) 1976-03-05
DE2303463C2 (en) 1986-05-28
FR2215212A1 (en) 1974-08-23
AU476180B2 (en) 1976-09-16
NL7400673A (en) 1974-07-22
CH574716A5 (en) 1976-04-30
IE38651L (en) 1974-07-18
SE422152B (en) 1982-02-22
DK134097B (en) 1976-09-13

Similar Documents

Publication Publication Date Title
GB1399888A (en) Injectable amino acid composition
IE800694L (en) Enzymatic producion of peptides.
SE7907316L (en) AMINOSYRALOSNING
Cho et al. A study on flavorous taste components in kimchis-on free amino acids
SE8101585L (en) NUTRITION COMPOSITION, AS WELL AS ITS ADMINISTRATION
GB1146337A (en) Meat flavor compositions
JPS5536457A (en) Amino acid infusion
ATE245999T1 (en) AMINO ACID COMPOSITIONS
IE38651B1 (en) Improvements in or relating to an aqueous lipid emulsion for parenteral alimentation
GB1394846A (en) Polypeptides
KR840008279A (en) Atomization Method of Amino Acid-Containing Fat Emulsion
GB1034358A (en) Body-protein-biosynthesis promoting composition
ATE31418T1 (en) MEDICATIONS CONTAINING TRIPEPTIDES.
SE7604987L (en) COMPOSITION FOR REPLACEMENT OF COFFEE PREPARATION
EP0740935A4 (en) Analgesic activity enhancer
GB1461106A (en) Gastric acid-inhibiting polypeptide
GB858333A (en) Flavouring substances and their preparation
GB1479017A (en) Polyptides process for their manufacture and their use as polyvalten inhibitors
GB1178149A (en) alpha-(N-Thiocarboxy)-Amino Acid Anhydrides
GB1353827A (en) Acthaction peptides and process for their manufacture
ATE46173T1 (en) PHARMACOLOGICALLY ACTIVE PEPTIDES.
GB1490079A (en) Process for the purification of peptides of the calcitonin type
KR920003960A (en) Method of manufacturing stabilized drinks
SU527182A1 (en) The method of obtaining protein hydrolysates from algae
GB1411184A (en) Polypeptides process for preparing them and their use as polyvalent isoinhibitors